These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38070541

  • 1. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    Wang E, Ahad T, Liu YA, Lee TK, Lui H, Crawford RI, Kalia S.
    J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
    [Abstract] [Full Text] [Related]

  • 2. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
    Chia BKY, Yew YW, Zhao X, Chong WS, Thng TGS.
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
    [Abstract] [Full Text] [Related]

  • 3. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
    Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M.
    Acta Derm Venereol; 2004 Jul; 84(5):370-4. PubMed ID: 15370703
    [Abstract] [Full Text] [Related]

  • 4. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 5. Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
    Åkerla P, Pukkala E, Helminen M, Korhonen N, Karppinen T.
    Acta Derm Venereol; 2024 Apr 17; 104():adv39927. PubMed ID: 38629891
    [Abstract] [Full Text] [Related]

  • 6. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
    Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M.
    Arch Dermatol Res; 2020 May 17; 312(4):249-253. PubMed ID: 31729594
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May 17; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 10. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
    Jo SJ, Kwon HH, Choi MR, Youn JI.
    Acta Derm Venereol; 2011 Jan 17; 91(1):40-3. PubMed ID: 21031281
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A, De Simone C, Perino F, Caldarola G, Peris K.
    J Dermatolog Treat; 2016 Oct 17; 27(5):443-7. PubMed ID: 26822468
    [Abstract] [Full Text] [Related]

  • 15. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
    Mimouni I, Shulman J, Unes AA, Pavlovsky L, Pavlotsky F.
    Photodermatol Photoimmunol Photomed; 2024 Jan 17; 40(1):e12936. PubMed ID: 38059681
    [Abstract] [Full Text] [Related]

  • 16. Carcinogenic risk in patients treated with UVA-1 phototherapy: A 5-year retrospective study.
    Cosetti D, Cioppa V, Rubegni P, Trovato E.
    Photodermatol Photoimmunol Photomed; 2024 May 17; 40(3):e12975. PubMed ID: 38787937
    [Abstract] [Full Text] [Related]

  • 17. Distinguishing Myth from Fact: Photocarcinogenesis and Phototherapy.
    Thompson KG, Kim N.
    Dermatol Clin; 2020 Jan 17; 38(1):25-35. PubMed ID: 31753190
    [Abstract] [Full Text] [Related]

  • 18. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 19. Treatments for psoriasis and the risk of malignancy.
    Patel RV, Clark LN, Lebwohl M, Weinberg JM.
    J Am Acad Dermatol; 2009 Jun 02; 60(6):1001-17. PubMed ID: 19344980
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
    Chao CH, Wu CY, Chou FL, Chen YJ.
    Clin Exp Dermatol; 2024 Apr 23; 49(5):459-465. PubMed ID: 38056487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.